Lilly sues online vendors, medical spa
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets.
In Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...
Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...
Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...
Lilly Ledbetter may have lost in the court of law, but she won in the court of public opinion as she brought attention to the ...
Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...
Her willingness to challenge the status quo helped shape a new era in corporate responsibility, writes Marc Benioff.
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback